Cabiate, Italy

Monica Abbondi

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Monica Abbondi: Innovator in Proteolytic Enzymes

Introduction

Monica Abbondi is a notable inventor based in Cabiate, Italy. She has made significant contributions to the field of proteolytic enzymes, particularly in relation to gluten intolerance. Her work focuses on developing innovative solutions to address health issues associated with gluten.

Latest Patents

Monica Abbondi holds 1 patent related to a new family of proteolytic enzymes. These enzymes have the ability to hydrolyze gluten oligopeptides at a pH between 3 and 8, which are resistant to cleavage by gastric and pancreatic enzymes. The invention aims to mitigate toxic effects caused by these oligopeptides in the intestinal lumen. The enzymes identified as endopeptidases of the S8/S53 family are produced by native strains. Additionally, the invention includes methods for producing enzyme compositions through the cultivation of native strains, mutants, or recombinant host cells containing nucleic acids coding for the endopeptidases. These enzyme compositions are useful for treating and preventing celiac sprue, dermatitis herpetiformis, and other disorders associated with gluten intolerance.

Career Highlights

Throughout her career, Monica Abbondi has worked with esteemed organizations such as Fondazione Is. Insubrico Di Ricerca Per La Vita and Fondazione Istituto Insubrico Di Ricerca Per La Vita. Her research and innovations have contributed to advancements in the understanding and treatment of gluten-related disorders.

Collaborations

Monica has collaborated with notable colleagues, including Linda Cavaletti and Lucia Carrano. These partnerships have further enhanced her research and development efforts in the field of proteolytic enzymes.

Conclusion

Monica Abbondi's innovative work in the development of proteolytic enzymes represents a significant advancement in addressing gluten intolerance. Her contributions have the potential to improve the quality of life for individuals affected by gluten-related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…